{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:59:03Z","timestamp":1775487543376,"version":"3.50.1"},"reference-count":95,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJWH"],"DOI":"10.2147\/ijwh.s372597","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T23:50:14Z","timestamp":1663285814000},"page":"1337-1350","source":"Crossref","is-referenced-by-count":22,"title":["Mirabegron in the Management of Overactive Bladder Syndrome"],"prefix":"10.2147","volume":"Volume 14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9002-0763","authenticated-orcid":true,"given":"Miriam","family":"O'Kane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dudley","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5372-530X","authenticated-orcid":true,"given":"Adrian","family":"Wagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","volume":"21","author":"Haylen","year":"2010","journal-title":"Int Urogynecol J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1464-410X.2010.09993.x","volume":"108","author":"Irwin","year":"2011","journal-title":"BJU Int"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1524-4733.2004.74008.x","volume":"7","author":"Coyne","year":"2004","journal-title":"Value Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/j.1464-410X.2008.07601.x","volume":"101","author":"Coyne","year":"2008","journal-title":"BJU Int"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/j.1464-410X.2010.10013.x","volume":"108","author":"Coyne","year":"2011","journal-title":"BJU Int"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/j.1743-6109.2011.02250.x","volume":"8","author":"Coyne","year":"2011","journal-title":"J Sex Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.juro.2009.12.060","volume":"183","author":"Kanai","year":"2010","journal-title":"J Urol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/TCRM.S33052","volume":"9","author":"Andersson","year":"2013","journal-title":"Ther Clin Risk Manag"},{"key":"ref10","first-page":"935","volume":"10","author":"Imran","year":"2013","journal-title":"Urol J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.09.050","volume":"62","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/MOU.0b013e32832ce8a4","volume":"19","author":"Andersson","year":"2009","journal-title":"Curr Opin Urol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1111\/j.1464-410X.2012.11023.x","volume":"110","author":"Wagg","year":"2012","journal-title":"BJU Int"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/j.1464-410X.2009.09035.x","volume":"105","author":"Brubaker","year":"2009","journal-title":"BJU Int"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00192-013-2250-4","volume":"25","author":"Sicras-Mainar","year":"2014","journal-title":"Int Urogynecol J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"ref17","first-page":"191","volume":"9","author":"Staskin","year":"2007","journal-title":"Rev Urol Fall"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1152\/physrev.00038.2003","volume":"84","author":"Andersson","year":"2004","journal-title":"Physiol Rev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00210-008-0274-y","volume":"377","author":"Otsuka","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref20","first-page":"1367","volume":"288","author":"Takeda","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/01.ju.0000067621.62736.7c","volume":"170","author":"Nomiya","year":"2003","journal-title":"J Urol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1517\/17460441.2014.892923","volume":"9","author":"Sacco","year":"2014","journal-title":"Expert Opin Drug Discov"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1124\/jpet.107.125757","volume":"323","author":"Hicks","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.106.115840","volume":"321","author":"Takasu","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref25","unstructured":"US Food and Drug Administration [homepage on intranet]. Approved drug products with therapeutic equivalence evaluations; 2020. Available from: https:\/\/www.fda.gov\/media\/136324\/download. Accessed April 10, 2022."},{"key":"ref26","unstructured":"European Medicines Agency [homepage on the intranet]. Amsterdam: human medicine European public assessment report (EPAR): betmiga; 2012. Available from: https:\/\/www.ema.europa.eu\/en. Accessed January 20, 2015."},{"key":"ref27","unstructured":"Astellas [press release]. FDA approves overactive bladder treatment myrbetriqTM (mirabegron) from Astellas; 2012. Available from: https:\/\/www.astellas.com\/en\/. Accessed March 13, 2015."},{"key":"ref28","unstructured":"Australian Therapeutic Goods Administration [homepage on the intranet]. Australian public assessment report: mirabegron; 2014. Available from: https:\/\/www.tga.gov.au. Accessed April 14, 2022."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00441-010-1053-x","volume":"342","author":"Limberg","year":"2010","journal-title":"Cell Tissue Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00210-012-0814-3","volume":"386","author":"Hatanaka","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.eururo.2012.08.056","volume":"62","author":"Aizawa","year":"2012","journal-title":"Eur Urol"},{"key":"ref32","unstructured":"US Food and Drug Administration [homepage on intranet]. Center for drug evaluation and research pharmacology review(s); 2012. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/202611Orig1s000PharmR.pdf. Accessed March 16, 2022."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.clinthera.2012.09.010","volume":"34","author":"Krauwinkel","year":"2012","journal-title":"Clin Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40261-013-0146-1","volume":"34","author":"Iitsuka","year":"2014","journal-title":"Clin Drug Investig"},{"key":"ref35","unstructured":"US Food and Drug Administration [homepage on intranet]. Center for drug evaluation and research clinical pharmacology and biopharmaceutics review(s); 2012. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/202611Orig1s000ClinPharmR.pdf. Accessed March 22, 2022."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1124\/dmd.111.043588","volume":"40","author":"Takusagawa","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clinthera.2015.02.021","volume":"37","author":"Iitsuka","year":"2015","journal-title":"Clin Ther"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/nau.22373","volume":"32","author":"Chapple","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00192-013-2042-x","volume":"24","author":"Chapple","year":"2013","journal-title":"Int Urogynecol J"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/clpt.2012.181","volume":"92","author":"Malik","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.eururo.2012.10.016","volume":"63","author":"Khullar","year":"2013","journal-title":"Eur Urol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2490-13-45","volume":"13","author":"Khullar","year":"2013","journal-title":"BMC Urol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.juro.2012.10.017","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.urology.2013.02.077","volume":"82","author":"Herschorn","year":"2013","journal-title":"Urology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1185\/03007995.2016.1149806","volume":"32","author":"Wagg","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/luts.12053","volume":"7","author":"Yamaguchi","year":"2015","journal-title":"Low Urin Tract Symptoms"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.urology.2015.01.002","volume":"85","author":"Matsukawa","year":"2015","journal-title":"Urology"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/nau.22645","volume":"34","author":"Kuo","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/bju.12649","volume":"113","author":"Yamaguchi","year":"2014","journal-title":"BJU Int"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/iju.14700","volume":"29","author":"Takahashi","year":"2022","journal-title":"Int J Urol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.eururo.2012.10.048","volume":"63","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/luts.12107","author":"Yamaguchi","year":"2015","journal-title":"Low Urin Tract Symptoms"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/ijcp.12433","volume":"68","author":"Nitti","year":"2014","journal-title":"Int J Clin Pract"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.eururo.2015.09.007","volume":"69","author":"Rosa","year":"2016","journal-title":"Eur Urol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/1756287215589250","volume":"7","author":"Batista","year":"2015","journal-title":"Ther Adv Urol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.eururo.2019.10.002","volume":"77","author":"Wagg","year":"2020","journal-title":"Eur Urol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40266-020-00783-w","volume":"37","author":"Herschorn","year":"2020","journal-title":"Drugs Aging"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12877-020-1474-7","volume":"20","author":"Griebling","year":"2020","journal-title":"BMC Geriatr"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.eururo.2016.02.007","volume":"70","author":"Blais","year":"2016","journal-title":"Eur Urol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4111\/icu.20200380","volume":"62","author":"Kim","year":"2021","journal-title":"Investig Clin Urol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1159\/000515992","volume":"105","author":"Soliman","year":"2021","journal-title":"Urol Int"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/nau.24657","volume":"40","author":"Baka-Ostrowska","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22844","author":"Khullar","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1007\/s12325-019-00994-7","volume":"36","author":"Carlson","year":"2019","journal-title":"Adv Ther"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s11136-014-0904-4","volume":"24","author":"Castro-Diaz","year":"2015","journal-title":"Qual Life Res"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1524-4733.2005.00041.x","volume":"8","author":"Yu","year":"2005","journal-title":"Value Health"},{"key":"ref67","unstructured":"World Health Organization. Adherence to long-term therapies: evidence for action; 2003. Available from: http:\/\/www.who.int\/chp\/knowledge\/publications\/adherence_report\/en\/. Accessed May 6, 2015."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00228-008-0600-9","volume":"65","author":"Brostrom","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S1569-9056(15)60264-0","volume":"14","author":"Wagg","year":"2015","journal-title":"Eur Urol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"A471","DOI":"10.1016\/j.jval.2014.08.1336","volume":"17","author":"Wagg","year":"2014","journal-title":"Value Health"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5489\/cuaj.3098","volume":"9","author":"Wagg","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/luts.12382","volume":"13","author":"Carlson","year":"2021","journal-title":"Low Urin Tract Symptoms"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-016-2945-4","author":"Duckett","year":"2016","journal-title":"Int Urogynecol J"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22943","author":"Pindoria","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00192-017-3377-5","volume":"29","author":"Staskin","year":"2018","journal-title":"Int Urogynecol J"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12955-018-0892-0","volume":"16","author":"Herschorn","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.eururo.2014.02.012","volume":"67","author":"Abrams","year":"2015","journal-title":"Eur Urol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00345-016-1908-1","volume":"35","author":"Abrams","year":"2017","journal-title":"World J Urol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/bju.13882","volume":"120","author":"Herschorn","year":"2017","journal-title":"BJU Int"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/jcph.1107","volume":"58","author":"White","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/MBP.0000000000000320","volume":"23","author":"Weber","year":"2018","journal-title":"Blood Press Monit"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/nau.23919","volume":"38","author":"Mueller","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.030","author":"Drake","year":"2016","journal-title":"Eur Urol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12944","volume":"71","author":"Drake","year":"2017","journal-title":"Int J Clin Pract"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.euf.2017.08.008","volume":"3","author":"Gibson","year":"2017","journal-title":"Eur Urol Focus"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/bju.13068","volume":"116","author":"Yamaguchi","year":"2015","journal-title":"BJU Int"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/iju.13868","volume":"26","author":"Yamaguchi","year":"2019","journal-title":"Int J Urol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1442-2042.2005.01066.x","volume":"12","author":"Takei","year":"2005","journal-title":"Int J Urol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1442-2042.2008.02152.x","volume":"15","author":"Homma","year":"2008","journal-title":"Int J Urol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/luts.12286","volume":"12","author":"Katoh","year":"2020","journal-title":"Low Urin Tract Symptoms"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.archger.2015.06.006","volume":"61","author":"Kosilov","year":"2015","journal-title":"Arch Gerontol Geriatr"},{"key":"ref92","unstructured":"NICE. NICE technology appraisal guidance [TA290] Mirabegron for treating symptoms of overactive bladder; 2013. Available from: https:\/\/www.nice.org.uk\/guidance\/ta290. Accessed March 12, 2015."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40261-014-0240-z","volume":"35","author":"Aballea","year":"2015","journal-title":"Clin Drug Investig"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jval.2015.05.011","volume":"18","author":"Nazir","year":"2015","journal-title":"Value Health"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3111\/13696998.2014.995300","volume":"18","author":"Nazir","year":"2015","journal-title":"J Med Econ"}],"container-title":["International Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=83978","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=83978","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T23:50:25Z","timestamp":1663285825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/mirabegron-in-the-management-of-overactive-bladder-syndrome-peer-reviewed-fulltext-article-IJWH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":95,"URL":"https:\/\/doi.org\/10.2147\/ijwh.s372597","relation":{},"ISSN":["1179-1411"],"issn-type":[{"value":"1179-1411","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}